A detailed history of Octagon Capital Advisors LP transactions in Cybin Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 18,604,650 shares of CYBN stock, worth $186 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
18,604,650
Previous 18,604,650 -0.0%
Holding current value
$186 Million
Previous $7.63 Million 34.14%
% of portfolio
1.16%
Previous 1.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.3 - $0.46 $5.58 Million - $8.56 Million
18,604,650 New
18,604,650 $7.63 Million

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.66B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.